Arbovirus Testing Market 2024-2028: Size and High cost of rapid diagnostic products; growth driven by the End-user, Some of key Companies Positioned Strategically
The arbovirus testing market size by End-user (Diagnostic laboratories, Hospitals, Research centers, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 250.1 million. The market is expected to grow at a CAGR of 4.5% between 2024 and 2028.
- Arboviruses pose a significant risk to global communities, necessitating robust testing capabilities in public health laboratories. However, the absence of standardization in arbovirus testing services is a major impediment, increasing costs for hospitals, clinics, and diagnostics laboratories. The utilization of advanced testing equipment for diagnosis comes with substantial expenses. For instance, the average annual cost to treat hospitalized West Nile Virus (WNV) patients can surpass USD700,000 per patient. Furthermore, the intricate process of collecting a reverse transcription-polymerase chain reaction (RT-PCR) sample, which is the gold standard for arbovirus diagnosis, is costly and demanding. The sample preparation process necessitates highly skilled operators, adding to the overall complexity and expense.
- The arbovirus testing market witnesses significant growth due to the increasing prevalence of arboviral diseases and the need for early and accurate diagnosis. Laboratories and diagnostic centers invest in advanced technologies, such as real-time PCR and ELISA, to enhance their testing capabilities and meet the rising demand. Government initiatives and collaborations with key players further fuel market expansion.
Access the full report to know who are the other key countries segment-wise forecast and historic data
Some of the Key Companies:
- Abbott Laboratories
- AESKU.GROUP GmbH and Co. KG
- Agilent Technologies Inc.
- ARUP Laboratories
- Bio Rad Laboratories Inc.
- BioAgilytix Labs
- Copley Scientific Ltd.
- DiaSorin SpA
- Distek Inc.
- Fluke Biomedical
- Laboratory Corp. of America Holdings
- Mayo Foundation for Medical Education and Research
- Merck KGaA
- NovaTec Immundiagnostica GmbH
- Perkin Elmer Inc.
- Response Biomedical Corp.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/